This is why the US is blocking the Johnson & Johnson vaccine
Fda and CDC in the US ask to suspend the administration of the Johnson & Johnson vaccine. Six women developed a rare disease within two weeks of inoculating the drug. All the details
The US suspends the administration of the Johnson & Johnson single-dose anti Covid-19 vaccine.
The Food and Drug Administration and the Centers for Disease Control will stop using the Johnson & Johnson vaccine at federal sites and, writes The New York Times , will also urge individual states to suspend administration, pending drug safety checks, after some cases of blood clots. All the details.
WHAT HAPPENED
Six US women, aged 18 to 48, who were given the Johnson & Johnson-owned Janssen vaccine developed a rare disease that causes blood clots within about two weeks of vaccination.
A woman died as a result of this disease. A second woman, in Nebraska, was hospitalized in critical condition
SUSPENSION IS RECOMMENDED
The facts prompted the FDA and the CDC to recommend stopping the administration of the drug. "We are recommending a pause in the use of this vaccine for excess of caution," said Dr. Peter Marks, director of the Food and Drug Administration's Center for Biological Evaluation and Research, and Dr. Anne Schuchat, Deputy Chief Director of the CDC. , in a joint statement.
“At this time, these adverse events appear to be extremely rare,” they added.
GOVERNMENT SUSPENDS ADMINISTRATION
The one received by the health authorities is only a recommendation to suspend. The federal government, however, should suspend vaccine administration at all managed vaccination sites, and that decision should also be made by state health officials.
Ohio Governor Mike DeWine, a Republican, temporarily stopped Johnson & Johnson's inoculation of the vaccine.
CHECKS ON SAFETY IN PROGRESS
The FDA and the CDC, together with external experts, will examine the possible connections between what happened to the six women and the vaccine, determining whether to continue to authorize the use of the vaccine for all adults or to limit the authorization.
An emergency meeting of the external advisory committee of the CDC has already been scheduled for Wednesday 14 April.
VACCINAL CAMPAIGN AT RISK?
The stop will slow down the American vaccination campaign, without however upsetting the program. "The vast majority of the nation's vaccine supply comes from two other manufacturers, Pfizer-BioNTech and Moderna, who together supply over 23 million doses a week of their two-shot vaccines," explains The New York Times , adding that there have been significant safety concerns for any of these vaccines ”.
The Astrazeneca vaccine has not yet been approved for emergency use in the US .
This is a machine translation from Italian language of a post published on Start Magazine at the URL https://www.startmag.it/sanita/ecco-perche-gli-usa-bloccano-il-vaccino-di-johnson-johnson/ on Tue, 13 Apr 2021 14:36:30 +0000.